About the Company
We do not have any company description for ADIAL PHARMACEUTICALS, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ADIL News
Adial Pharmaceuticals Inc (ADIL) Shares Decline Despite Market Challenges
Adial Pharmaceuticals Inc (NASDAQ: ADIL)’s stock price has gone decline by -21.81 in comparison to its previous close of 2.98, however, the company has experienced a 100.86% increase in its stock ...
EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance
Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered ...
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Received Favorable Feedback from US and EU Regulatory Agencies Advancing Discussions with Potential Strategic Partners ...
Adial Pharmaceuticals posts promising update on alcohol disorder drug
Adial Pharmaceuticals Inc (NASDAQ: ADIL) is up 60% today following a promising update on its alcohol disorder drug. What it ...
Adial stock rallies 81% on data for alcohol abuse drug
Adial (ADIL) stock rallied 81% in morning trading Wednesday amid the publication of encouraging data for the company's ...
Biopharma Stock News Bite - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Spikes on News Potential Treatment for Alcohol Use Disorder
Investorideas.com ( Biotech Stock News Bites - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a clinical-stage biopharmaceutical ...
Adial Pharmaceuticals Inc ADIL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Received $4.3 Million in Gross Proceeds from Warrant Exercises Subsequent to Year-End 2023 GLEN ALLEN, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW ...
Adial Pharmaceuticals Inc ADIL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Adial Pharmaceuticals Inc (ADIL)
Benzinga - by Lisa Levin, Benzinga Editor. Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday. Lipella Pharmaceuticals ...
Loading the latest forecasts...